Attention IASLC Voting Members!!

Check your email for "Your Vote Matters: Cast Your Ballot on IASLC Bylaws Today" to cast your ballot, or contact membership@iaslc.org

History

For nearly 50 years, the IASLC has helped shape the field of lung cancer care.
About Us_History_banner
The IASLC's History

The IASLC's History

In 1972, in response to the overwhelming need for collaboration and a growing concern for public health, Drs. David T. Carr, Oleg S. Selawry, Lawrence Broder, Clifton Mountain and George Higgins began building an international, multidisciplinary organization. In 1974, the group launched the International Association for the Study of Lung Cancer (IASLC) at their first formal meeting in Florence, Italy, having recruited more than 250 founding members from across the globe and with different perspectives.

Since then, the IASLC has grown into a professional, international organization of more than 8,000 members. Global experts have come to rely on the IASLC’s World Conference on Lung Cancer, Journal of Thoracic Oncology, as well as on its scientific programs and educational events to inform their practice of medicine, research and patient care. From doctors, nurses and allied health professionals to scientists, patients and advocates, the IASLC continues to unite people around the goal of eradicating lung and thoracic cancers.

IASLC 50 Year History Book

order the 50TH ANNIVERSARY BOOK

You have all played a role in the success of the IASLC. Remember this occasion for years to come with the special 50th Anniversary edition of our history book! Don't miss out, order your copy of the book today.

 

History of the World Conference on Lung Cancer
 

70s1st-wclc-resize163x336.jpg

Each year, the IASLC hosts its signature event, the IASLC World Conference on Lung Cancer (WCLC). The inaugural WCLC brought together a small collection of specialists on Hilton Head Island in 1978. 

Over 40 years later, the WCLC has become the largest global event dedicated solely to lung cancer and other thoracic malignancies, attracting over 7,000 attendees from across the lung cancer community, including physicians, investigators, nurses, allied health professionals, survivors and patients.

In 2019, the IASLC held its 20th WCLC in Barcelona, Spain, drawing a record-breaking 7,750 attendees from over 100 countries. 

Through the hard work of the IASLC leadership and staff, as well as our local organizing committee, the meeting will undoubtedly serve as an invaluable resource for the continuing education of the global lung cancer community. 

For more information about this year's WCLC, please visit the official WCLC website.

History of the Chief Executive Officer

In 1994 the IASLC appointed Dr. Heine H. Hanson as its Executive Director, to manage the association's operations, initiatives and staff. Under the leadership of Dr. Hanson and his successors Dr. Paul Bunn Jr., Dr. Fred R. Hirsch, Dave Mesko, and Dr. Karen Kelly the IASLC experienced growth in terms of staffing, membership, activities, and overall impact. 

Image
Karen Kelly

Karen Kelly

Chief Executive Officer, 2022 - Present

United States

Dr. Kelly is the CEO of the International Association for the Study of Lung Cancer (IASLC), the only global network dedicated to the study and eradication of lung cancer and other thoracic malignancies. She is an internationally recognized lung cancer expert dedicated to providing enhanced cancer care through cutting-edge clinical trials. Her research spans the spectrum of this disease from prevention to treatment. Dr. Kelly is widely published, and she frequently lectures on lung cancer topics, nationally and internationally. Dr. Kelly is a long-standing active member of IASLC, ASCO, and SWOG. She served as the SWOG Lung Committee Chair from 2016 until 2022.

Dr. Kelly earned her medical degree from the University of Kansas School of Medicine. She completed her internal medicine residency and oncology fellowship at the University of Colorado Health Sciences Center in Denver, Colorado. Dr. Kelly was appointed faculty at the University of Colorado where she spent many years building her academic career in thoracic oncology prior to accepting a faculty appointment at the University of California, Davis where she held the Jennifer Rene Harmon Tegley and Elizabeth Erica Harmon Endowed Chair in Clinical Cancer Research and was the Associate Director for Clinical Research for their NCI designated comprehensive cancer center.

Image
Dave Mesko

Dave Mesko

Chief Executive Officer, 2018-2021

United States

Dave Mesko served as the IASLC' Chief Executive Officer from 2018-2021. Dave brought a wealth of knowledge in management, finance, strategy, and process to the CEO position. Navigating the staff by honoring the association's past, embracing the present, and planning for the future. 

Image
Headshot of Dr. Fred R. Hirsch

Fred R. Hirsch

Chief Executive Officer, 2013-2018

United States

Dr. Fred R. Hirsch served as the IASLC's CEO from 2013 - 2018. Under his leadership, the IASLC's membership doubled while moving into a stronger financial position. The Journal of Thoracic Oncology moved to a new publisher resulting in significant growth of the impact factor. 

Image
Paul Bunn

Paul A. Bunn Jr.

Chief Executive Officer, 2003-2013

United States

Dr. Paul A. Bunn Served as the IASLC's CEO from 2003 - 2013, overseeing the launch of the Journal of Thoracic Oncology, significantly growing its membership, making significant contributions to screening, and establishing the World Conference on Lung Cancer as the largest international gathering of clinicians, researchers, and scientists in the field of lung cancer and thoracic oncology.

Image
Heine Hanson

Heine H. Hansen

Executive Director, 1994-2003

United States

Heine H. Hansen was a founder of the IASLC, eventually serving as Executive Director from 1994 - 2003. During his tenure, Dr. Hansen led the association to growth in membership and attendance at the World Conference on Lung Cancer, setting it on the strong course that it continues to enjoy today. 

History of The IASLC President

Throughout its long history, the IASLC has benefited from the strategic vision of its President. Many lung cancer luminaries have held this title since the mid-1970s when the organization was founded. Each leader has left an indelible mark, playing a fundamental role in its ongoing growth and development to ensure the IASLC remains a powerful resource in the fight against lung cancer. 

Image

Paul Van Schil

IASLC President

2023-2025

Image
Heather Wakelee

Heather Wakelee

IASLC President

2021-2023

Image
Tetsuya Mitsudomi

Tetsuya Mitsudomi

IASLC President

2019-2021

Image
Giorgio Scagliotti

Giorgio Scagliotti

IASLC President

2017-2019

Image
David Carbone

David Carbone

IASLC President

2015-2017

Image
tony_mok

Tony Mok

IASLC President

2013-2015

Image
Goldstraw_Peter

Peter Goldstraw

IASLC President

2011-2013

Image
David Gandara

David Gandara

IASLC President

2009 - 2011

Image
Nagahiro Saijo

Nagahiro Saijo

IASLC President

2007-2009

Image
Desmond Carney

Desmond Carney

IASLC President

2005-2007

Image
Frances Shepherd

Frances Shepherd

IASLC President

2003-2005

Image
Harubmi Kato

Harumbi Kato

IASLC President

2000-2003

Image
Giovanni Motta

Giovanni Motta

IASLC President

1997-2000

Image
Paul Bunn

Paul A. Bunn Jr.

IASLC President

1994-1997

Image
Yoshihiro Hayata

Yoshihiro Hayata

IASLC President

1991-1994

Image
Heine Hanson

Heine H. Hansen

IASLC President

1988-1991

Image
Ronald Vincent

Ronald Vincent

IASLC President

1985-1988

Image
Shiohiro Ishikawa

Shichiro Ishikawa

IASLC President

1982-1985

Image
Pierre Alberto

Pierre Alberto

IASLC President

1980-1982

Image
George Higgins

George Higgins

IASLC President

1978-1980

Image
Black and white image of Clifton Mountain

Clifton Mountain

IASLC President

1977-1978

Image
David Carr

David Carr

IASLC President

1976-1977

Image
Headshot of Oleg Selawry

Oleg Selawry

IASLC President

1974-1976